Juvederm volbella with lidocaine for lip and perioral enhancement: a prospective, randomized, controlled trial.

ABSTRACT:

Background

Juvéderm Volbella with Lidocaine is a new hyaluronic acid dermal filler.

Methods

In this prospective, randomized, multicenter study, 280 subjects desiring lip volume enhancement were treated with Juvéderm Volbella with Lidocaine or Restylane-L. Investigators rated treatment outcomes on Allergan's Lip Fullness Scale, Perioral Lines Scale, and Oral Commissures Severity Scale. A blinded independent central reviewer (ICR) assessed 3-dimensional digital photographs using these scales. Subjects evaluated outcomes using the FACE-Q Recovery Early Life Impact and Recovery Early Symptoms modules. The primary endpoint was noninferiority of Juvéderm Volbella with Lidocaine to Restylane-L based on responder rate (percentage of subjects with ≥1-point Lip Fullness Scale improvem

SUBMITTER: Raspaldo H 

PROVIDER: S-EPMC4387143 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature